Enzymotec Ltd. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, net revenues were $13,672,000 against $11,412,000 a year ago. Operating income was $163,000 against loss of $541,000 a year ago. Income before taxes on income was $394,000 against loss of $368,000 a year ago. Net income was $424,000 against loss of $330,000 a year ago. Earnings per basic and diluted share were $0.02 against loss of $0.01 a year ago. Adjusted EBITDA was $2,280,000 against $1,254,000 a year ago. Non-GAAP net income was $1,606,000 against $623,000 a year ago. Non-GAAP diluted EPS was $0.07 against $0.03 a year ago. For nine months, net revenues were $38,687,000 against $37,112,000 a year ago. Operating loss was $2,676,000 against profit of $966,000 a year ago. Loss before taxes on income was $2,055,000 against profit of $1,357,000 a year ago. Net loss was $1,856,000 against profit of $1,291,000 a year ago. Loss per basic and diluted share was $0.08 against EPS was $0.06 a year ago. Net cash provided by operating activities was $8,557,000 against $2,111,000 a year ago. Purchase of property, plant and equipment was $3,474,000 against $1,459,000 a year ago. Adjusted EBITDA was $3,012,000 against $5,592,000 a year ago. Non-GAAP net income was $889,000 against $3,539,000 a year ago. Non-GAAP diluted EPS was $0.04 against $0.15 a year ago.